Skip to content
Drug recall · FDA · Published February 12, 2020

Lupin Pharmaceuticals Inc. recalls Memantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx Only, Manufactured for: Lupin

Lupin Pharmaceuticals recalls 21mg Memantine Hydrochloride Extended Release Capsules due to failed dissolution tests. This may affect drug effectiveness. Check NDC 68180-248-06 and lot H900330 for affected products.

🇺🇸 FDA recall #D-0855-2020DrugLupin ›
Take action

Contact the company & request your remedy

Recalling firmLupin Pharmaceuticals Inc.Harborplace Tower, 111 S Calvert St Fl 21st · Baltimore, MD 21202-6174
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Lupin Pharmaceuticals is recalling 21 mg Memantine Hydrochloride Extended Release Capsules (30-count bottles) because they failed dissolution tests during stability studies. This could mean the medication doesn't work as intended, but the recall doesn: t mention immediate safety risks. Read more at govinfonow.com/recall/37374-lupin-memantine-capsules-recall-failed-dissolution-test-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/37374-lupin-memantine-capsules-recall-failed-dissolution-test-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0855-2020

Cite this page

“Lupin Memantine Capsules Recall: Failed Dissolution Test Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37374-lupin-memantine-capsules-recall-failed-dissolution-test-risk. Based on FDA recall #D-0855-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0855-2020%22&limit=1).

Why it’s dangerous

The capsules failed dissolution tests during a six-month stability study, meaning they may not release the medication properly over time. This could lead to inconsistent drug levels in the body, potentially reducing effectiveness.

Who’s affected

Prescription patients who received the specific 21 mg Memantine capsules with NDC 68180-248-06 and lot number H900330. Patients using these capsules for conditions like Alzheimer's disease are most at risk.

How to tell if you have this one

Check for the NDC code 68180-248-06 on the product label and lot number H900330. These capsules are prescription-only and manufactured by Lupin Pharmaceuticals.

  • Brand
    Lupin
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for NDC 68180-248-06 and lot number H900330 on the bottle.

✎ GovInfoNow

Questions people ask

Is this recall dangerous?

The recall is for potential effectiveness issues, not immediate safety risks. The official notice doesn't mention injuries or serious harm.

How do I know if I have the recalled product?

Check for NDC 68180-248-06 and lot number H900330 on the product label. These capsules are prescription-only.

What should I do if I have the recalled product?

The recall doesn't specify a remedy, so contact your doctor or pharmacist for advice.

Take action

Contact Lupin

We’ve drafted a message you can send Lupin to request your refund or repair — edit it as you like.

Subject: Recall D-0855-2020 — Lupin Lupin

Hello,

I own a Lupin that is covered by recall D-0855-2020 from Lupin.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0855-2020 (February 12, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0855-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA